Ketamine and Metabolite Quantitative, Serum or Plasma Ki-67 with Interpretation by Immunohistochemistry 17-Ketosteroids, Urine Ki-67, MIB-1, by Immunohistochemistry Kabuki Syndrome (KMT2D) Sequencing Kidney Stone Risk Panel, Urine
